Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Oncomed Pharmaceuticals Inc
Oncomed Pharmaceuticals
  

Oncomed Pharmaceuticals patents

Recent patent applications related to Oncomed Pharmaceuticals. Oncomed Pharmaceuticals is listed as an Agent/Assignee. Note: Oncomed Pharmaceuticals may have other listings under different names/spellings. We're not affiliated with Oncomed Pharmaceuticals, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "O" | Oncomed Pharmaceuticals-related inventors




Date Oncomed Pharmaceuticals patents (updated weekly) - BOOKMARK this page
02/16/17Immunotherapy with binding agents
07/13/17Notch binding agents and antagonists and methods of use thereof
06/29/17Notch1 receptor binding agents and methods of use thereof
06/29/17Vegf/dll4 binding agents and uses thereof
06/15/17Therapeutic combination and methods of treatment with a dll4 antagonist and an anti-hypertensive agent
02/16/17Immunotherapy with binding agents
01/26/17Methods for treating cancer with notch1 antiboides
01/26/17Notch3 antibodies and uses thereof
01/05/17Methods for identifying and isolating cells expressing a polypeptide
12/29/16Tigit-binding agents and uses thereof
12/22/16Compositions and methods for diagnosing and treating cancer
12/15/16Polynucleotides encoding vegf/dll4 binding agents
12/01/16Immunotherapy with binding agents
12/01/16Methods and monitoring of treatment with a wnt pathway inhibitor
11/17/16Methods and monitoring of treatment with a dll4 antagonist
11/10/16Methods for treating cancer with dll4 antagonists
11/10/16Frizzled-binding agents and uses thereof
11/03/16Met-binding agents and uses thereof
10/20/16Identification of predictive biomarkers associated with wnt pathway inhibitors
09/29/16Method for making heteromultimeric molecules
09/08/16Tnfrsf-binding agents and uses thereof
08/25/16Methods for treating cancers comprising k-ras mutations
08/18/16Methods of treating neuroendocrine tumors using frizzled-binding agents
06/30/16Compositions and methods for diagnosing and treating cancer
06/23/16Combination therapy for treatment of disease
06/16/16Treatment of fibrotic diseases
05/19/16Met-binding agents and uses thereof
04/21/16Rspo3 binding agents and uses thereof
03/24/16Wnt antagonist and methods of treatment and screening
02/25/16Compositions and methods for diagnosing and treating cancer
02/04/16Methods of treating pancreatic cancer
01/07/16Rspo binding agents and uses thereof
12/24/15Methods of treating ocular diseases
11/26/15Compositions and methods for treating and diagnosing cancer
11/05/15Methods for identifying and isolating cells expressing a polypeptide
11/05/15Human notch receptor mutations and their use
08/20/15Frizzled-binding agents and uses thereof
08/20/15Methods of treating hematological malignancies with notch1 antibodies
07/16/15Jagged-binding agents and uses thereof
07/16/15Notch binding agents and antagonists and methods of use thereof
07/02/15Compositions and methods for diagnosing and treating cancer
06/18/15Notch1 receptor binding agents and methods of use thereof
06/18/15Compositions and methods for treating and diagnosing cancer
05/14/15Combination therapy for treatment of cancer
04/30/15Therapeutic combination and methods of treatment with a dll4 antagonist and an anti-hypertensive agent
04/09/15Vegf/dll4 binding agents and uses thereof
01/08/15Rspo binding agents and uses thereof
01/08/15Rspo binding agents and uses thereof
11/27/14Compositions and methods for diagnosing and treating cancer
08/28/14Methods and monitoring of treatment with a wnt pathway inhibitor
08/14/14Methods and monitoring of treatment with a dll4 antagonist
08/07/14Methods and monitoring of treatment with a dll4 antagonist
07/17/14Ddr1-binding agents and methods of use thereof
07/03/14Immunotherapy with binding agents
07/03/14Compositions and methods for diagnosing and treating cancer
05/15/14Methods of treating neuroendocrine tumors using frizzled-binding agents
05/15/14Compositions and methods for treating and diagnosing cancer
03/06/14Methods for treating melanoma
01/16/14Rspo3 binding agents and uses thereof
01/09/14Notch1 receptor binding agents and methods of use thereof
01/02/14Methods for identifying and isolating cells expressing a polypeptide
01/02/14Methods for identifying and isolating cells expressing a polypeptide
12/05/13Antibodies that bind the glutamate ligand binding region of notch3
12/05/13Methods for treating cancer with dll4 antagonists
12/05/13Methods for treating cancer with notch2/3 antibodies
Patent Packs
10/03/13Notch binding agents and antagonists and methods of use thereof
09/26/13Compositions and methods for diagnosing and treating cancer
09/26/13Frizzled-binding agents and uses thereof
09/26/13Method for making heteromultimeric molecules
09/19/13Notch1 binding agents and methods of use thereof
06/27/13Vegf/dll4 binding agents and uses thereof
05/16/13Compositions and methods for treating and diagnosing cancer
05/09/13Compositions and methods for treating and diagnosing cancer
04/18/13Rspo binding agents and uses thereof
04/11/13Bone morphogenetic protein receptor binding agents and methods of their use
02/21/13Wnt-binding agents and uses thereof
02/07/13Wnt antagonists and methods of treatment and screening
01/31/13Antibodies to the notch1 receptor
11/29/12Jagged-binding agents and uses thereof
11/15/12Notch-binding agents and antagonists and methods of use thereof
Patent Packs
10/18/12Therapeutic combination and methods of treatment with a dll4 antagonist and an anti-hypertensive agent
08/23/12Notch1 binding agents and methods of use thereof
03/22/12Methods for treating melanoma
02/02/12Frizzled-binding agents and uses thereof
12/15/11Wnt antagonists and methods of treatment and screening
11/24/11Ddr1-binding agents and methods of use thereof
11/24/11Methods for identifying and isolating cells expressing a polypeptide
07/28/11Compositions and methods for treating and diagnosing cancer
07/07/11Methods for treating cancers comprising k-ras mutations
06/16/11Compositions and methods for diagnosing and treating cancer
05/26/11Method for making heteromultimeric molecules
12/16/10Compositions and methods for diagnosing and treating cancer
12/16/10Compositions and methods for diagnosing and treating cancer
05/06/10Notch-binding agents and antagonists and methods of use thereof







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Oncomed Pharmaceuticals in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Oncomed Pharmaceuticals with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';